Cervical cancer rates are on the rise among younger women, owing in part to a lack of screening and prevention.

Agnes Kathrine Lie, MD, PhD, Department of Pathology, and Gunnar Kristensen ... available HPV tests in the Norwegian Coordinated Cervical Cancer Screening Program, financially supported by ...

A safe alternative to clinician-administered tests, the self-test for HPV can help prevent cervical cancer. Read more at ...

Adding adjuvant chemotherapy to radiotherapy did not lead to a significant survival benefit over radiotherapy alone in women ...

Many of the annual cervical cancer cases originate in countries ... Those samples are sent out for pathology and the results are used for follow-up recommendations. If the diagnosis comes back ...

Evolution in women's cancer diagnostics: from histopathology to molecular testing, personalized treatment for breast, ovarian ...

The approval means that Libtayo is now the first immunotherapy approved in Europe to treat advanced cervical cancer, regardless of PD-L1 expression or tumour histology. The fourth leading cause of ...

Most had an ECOG performance score of 0, and most had FIGO (2009) stage IB1 (56%) and IB2 (34%) disease, along with squamous cell carcinoma histology ... stage high-risk cervical cancer that ...

Chemoradiation is standard therapy for cervical cancer, both in the primary setting ... The groups appeared balanced for performance status, histology, tumor grade and other clinical factors.